Related references
Note: Only part of the references are listed.A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms
Taymeyah Al-Toubah et al.
NEUROENDOCRINOLOGY (2020)
Cancer Genome Evolutionary Trajectories in Metastasis
Nicolai J. Birkbak et al.
CANCER CELL (2020)
Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
Takaaki Masuda et al.
CANCER SCIENCE (2020)
Paraneoplastic neutrophilic leukaemoid reaction in a patient with melanoma: association between tumour volume and leucocytosis
L. Fredeau et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
A pilot study of Bruton’s tyrosine kinase inhibitor ibrutinib alone and in combination with PD-1 inhibitor nivolumab in patients with metastatic solid tumors.
Brooke Benner et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
Aohan Hou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Myeloid Cell-Derived Arginase in Cancer Immune Response
Tomasz M. Grzywa et al.
FRONTIERS IN IMMUNOLOGY (2020)
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort
Kyle G. Mitchell et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Bruno Bockorny et al.
NATURE MEDICINE (2020)
Ibrutinib in Gynecological Malignancies and Breast Cancer: A Systematic Review
Julian Matthias Metzler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Looking backward in time to define the chronology of metastasis
Zheng Hu et al.
NATURE COMMUNICATIONS (2020)
Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
Mahmoud Mohammad Yaseen et al.
OPEN BIOLOGY (2020)
How the ageing microenvironment influences tumour progression
Mitchell Fane et al.
NATURE REVIEWS CANCER (2020)
Monocyte heterogeneity and functions in cancer
Claire E. Olingy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer
Zhigang Ma et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Pembrolizumab versus the standard of care for cancer therapy: A meta-analysis of 12 KEYNOTE trials comparing overall survival.
Nathaniel Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
O-002Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study
M Tempero et al.
ANNALS OF ONCOLOGY (2019)
Quantitative evidence for early metastatic seeding in colorectal cancer
Zheng Hu et al.
NATURE GENETICS (2019)
Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
Malgorzata Czystowska-Kuzmicz et al.
NATURE COMMUNICATIONS (2019)
Does early metastatic seeding occur in colorectal cancer?
Alessandro Magri et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells
Minjun C. Apodaca et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
Marijo Bilusic et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer
Rana Jahanban-Esfahlan et al.
CANCERS (2019)
440OPhase I study of the arginase inhibitor INCB001158 (1158) alone and in combination with pembrolizumab (PEM) in patients (Pts) with advanced/metastatic (adv/met) solid tumours
A Naing et al.
ANNALS OF ONCOLOGY (2019)
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
Richard P. Tobin et al.
FRONTIERS IN ONCOLOGY (2019)
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells
David K. Edwards et al.
BLOOD (2019)
1α, 25 dihydroxyvitamin D (1,25(OH)2D) inhibits the T cell suppressive function of myeloid derived suppressor sells (MDSC)
James C. Fleet et al.
CANCER RESEARCH (2019)
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors
David Hong et al.
ONCOLOGY (2019)
Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors
Robert Wesolowski et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
Lillian Sun et al.
JCI INSIGHT (2019)
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
David M. Peereboom et al.
JCI INSIGHT (2019)
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib
Cesarina Giallongo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy
Nicola R. Hardwick et al.
CLINICAL CANCER RESEARCH (2018)
Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients
Swati Khanna et al.
CLINICAL CANCER RESEARCH (2018)
A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation
Giuscppe Giaccone et al.
CLINICAL LUNG CANCER (2018)
Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis
Chong Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples
David K. Edwards V et al.
Oncotarget (2018)
The Involvement of Arginase and Nitric Oxide Synthase in Breast Cancer Development: Arginase and NO Synthase as Therapeutic Targets in Cancer
Nikolay Avtandilyan et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Rebekka Weber et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
Viktor Fleming et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
Richard P. Tobin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis
Wei Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers
Shan Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
Alice Tzeng et al.
TARGETED ONCOLOGY (2018)
Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity
Marte Fauskanger et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune regulation and anti-cancer activity by lipid inflammatory mediators
Saraswoti Khadge et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Dormant tumour cells, their niches and the influence of immunity
Erica T. Goddard et al.
NATURE CELL BIOLOGY (2018)
Ibrutinib Treatment Reduces Myeloid Derived Suppressor Cell Numbers and Function in Chronic Lymphocytic Leukemia
Gerardo Ferrer et al.
BLOOD (2018)
Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma
Robert J. Motzer et al.
ONCOLOGIST (2017)
Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
Arko Dasgupta et al.
MOLECULAR ONCOLOGY (2017)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
Yago Pico de Coana et al.
ONCOTARGET (2017)
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
Jessica C. Hassel et al.
ONCOIMMUNOLOGY (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
Susanne M. Steggerda et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration
Joseph Markowitz et al.
SCIENTIFIC REPORTS (2017)
Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer
Charli Dominguez et al.
JCI INSIGHT (2017)
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer
Robert Wesolowski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Bruton's tyrosine kinase (BTK) as a promising target in solid tumors
J. Molina-Cerrillo et al.
CANCER TREATMENT REVIEWS (2017)
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
Clemence Granier et al.
ESMO OPEN (2017)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
Andrew Stiff et al.
CANCER RESEARCH (2016)
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen
Emeric Limagne et al.
CANCER RESEARCH (2016)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Roger Geiger et al.
CELL (2016)
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens et al.
CLINICAL CANCER RESEARCH (2016)
Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
Emma Eriksson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau et al.
NATURE (2016)
G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers
Wenbin Li et al.
PROTEIN & CELL (2016)
Improving cancer immunotherapy by targeting the STATe of MDSCs
Nienke de Haas et al.
ONCOIMMUNOLOGY (2016)
JAK1/2 inhibition impairs T cell function invitro and in patients with myeloproliferative neoplasms
Sowmya Parampalli Yajnanarayana et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients
A. Gey et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Joseph A. Califano et al.
CLINICAL CANCER RESEARCH (2015)
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
Christoffer Gebhardt et al.
CLINICAL CANCER RESEARCH (2015)
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
Hui-Ming Chen et al.
CLINICAL CANCER RESEARCH (2015)
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
Herbert I. Hurwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Mathematical models of the steps involved in the systemic delivery of a chemotherapeutic to a solid tumor: From circulation to survival
Martin B. Ulmschneider et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Modulation of the tumor vasculature and oxygenation to improve therapy
Dietmar W. Siemann et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Donald T. Weed et al.
CLINICAL CANCER RESEARCH (2015)
Bone specific immunity and its impact on metastasis
Nikola Baschuk et al.
BONEKEY REPORTS (2015)
The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer
Nicola E. Annels et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
Christiane Meyer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy
Yago Pico de Coana et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes
Julia Kanterman et al.
CANCER RESEARCH (2014)
Metastases in Immune-Mediated Dormancy: A New Opportunity for Targeting Cancer
Irene Romero et al.
CANCER RESEARCH (2014)
Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration
Edmund K. Bartlett et al.
CLINICAL CANCER RESEARCH (2014)
The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response
Erika J. Schneble et al.
IMMUNOTHERAPY (2014)
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
Robert Coleman et al.
LANCET ONCOLOGY (2014)
Metastatic sites and survival in lung cancer
M. Riihimaeki et al.
LUNG CANCER (2014)
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Steven L. Highfill et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Adjuvants and myeloid-derived suppressor cells: Enemies or allies in therapeutic cancer vaccination
Audry Fernandez et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma
Kimberly A. Noonan et al.
CANCER IMMUNOLOGY RESEARCH (2014)
OPINION Challenges in circulating tumour cell research
Catherine Alix-Panabieres et al.
NATURE REVIEWS CANCER (2014)
The pre-metastatic niche: finding common ground
Jaclyn Sceneay et al.
CANCER AND METASTASIS REVIEWS (2013)
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
Dennis Lindau et al.
IMMUNOLOGY (2013)
Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer
Sokratis Trellakis et al.
INNATE IMMUNITY (2013)
Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
Linda Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
Yago Pico de Coana et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer
Robert Wesolowski et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
The metastatic niche and stromal progression
Jonathan P. Sleeman
CANCER AND METASTASIS REVIEWS (2012)
Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth
Matthew R. Porembka et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
Claudia A. Dumitru et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives
Patrick Raber et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients
I. Poschke et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples
Athanasios Kotsakis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Tumor-Expressed Inducible Nitric Oxide Synthase Controls Induction of Functional Myeloid-Derived Suppressor Cells through Modulation of Vascular Endothelial Growth Factor Release
Padmini Jayaraman et al.
JOURNAL OF IMMUNOLOGY (2012)
Differential Immunologic and MicroRNA Effects of 2 Dosing Regimens of Recombinant Human Granulocyte/Macrophage Colony Stimulating Factor
Pierre L. Triozzi et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Origins of tumor-associated macrophages and neutrophils
Virna Cortez-Retamozo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Many mechanisms mediating mobilization: an alliterative review
Jonathan Hoggatt et al.
CURRENT OPINION IN HEMATOLOGY (2011)
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
James Finke et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
Nicole Saenger et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy
Stephanie L. Hines et al.
BREAST (2010)
Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
Isabel Poschke et al.
CANCER RESEARCH (2010)
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
James E. Talmadge et al.
CANCER RESEARCH (2010)
INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect
Alberto A. Chiappori et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Use of α,25-Dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma
Jarrett E. Walsh et al.
HUMAN IMMUNOLOGY (2010)
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2010)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
Splenic metastases-not a frequent problem, but an underestimate location of metastases: epidemiology and course
Joerg Sauer et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Cesar A. Corzo et al.
JOURNAL OF IMMUNOLOGY (2009)
The critical role of the bone microenvironment in cancer metastases
Sandra Casimiro et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Parallel progression of primary tumours and metastases
Christoph A. Klein
NATURE REVIEWS CANCER (2009)
Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer
Nikolas H. Stoecklein et al.
CANCER CELL (2008)
Comparative lesion sequencing provides insights into tumor evolution
Sian Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Clonal selection of metastasis within the life history of a tumor
James E. Talmadge
CANCER RESEARCH (2007)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Inflammatory cell infiltration of tumors: Jekyll or Hyde
James E. Talmadge et al.
CANCER AND METASTASIS REVIEWS (2007)
Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma
Cecilia Melani et al.
CANCER RESEARCH (2007)
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
Yulia Nefedova et al.
CANCER RESEARCH (2007)
Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy
James E. Talmadge
CLINICAL CANCER RESEARCH (2007)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
Hiroaki Yanagimoto et al.
CANCER SCIENCE (2007)
L-arginine availability regulates T-lymphocyte cell-cycle progression
Paulo C. Rodriguez et al.
BLOOD (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
TCR ζ down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs
Analia V. Ezernitchi et al.
JOURNAL OF IMMUNOLOGY (2006)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer
JA Schardt et al.
CANCER CELL (2005)
Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases
MJ Xu et al.
BLOOD (2005)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib
AL Dewar et al.
BLOOD (2005)
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination
C De Santo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3
DMR Lathers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Chemiluminescence and LC-MS/MS analyses for the study of nitric oxide release and distribution following oral administration of nitroaspirin (NCX 4016) in healthy volunteers
M Carini et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management
J Crawford et al.
CANCER (2004)
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells
P Serafini et al.
CANCER RESEARCH (2004)
Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of IκB
K Chang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2004)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans
S Fiorucci et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Extramedullary haematopoiesis in massive hepatic necrosis
CEH Craig et al.
HISTOPATHOLOGY (2004)
Gene expression profiles of primary breast tumors maintained in distant metastases
B Weigelt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors
JW Gray
CANCER CELL (2003)
From latent disseminated cells to overt metastasis:: Genetic analysis of systemic breast cancer progression
O Schmidt-Kittler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
GM-CSF-secreting melanoma vaccines
G Dranoff
ONCOGENE (2003)
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741
ML Citron et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
CA Klein et al.
LANCET (2002)
Regulation of T cell receptor CD3 chain expression by L-arginine
PC Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand
B Heissig et al.
CELL (2002)
Distinctive features of nurselike cells that differentiate in the context of chronic lymphocytic leukemia
N Tsukada et al.
BLOOD (2002)
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism
A Mazzoni et al.
JOURNAL OF IMMUNOLOGY (2002)
An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2
S Yokochi et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Share Paper
